For the Inventor, By the Inventor

Enter inventor name

Scotch Plains, NJ, United States of America

Thierry Olivier Fischmann

USPTO Granted Patents = 22 (Patent Applications = 4)

CIPO Patents = 2

EPO Patents = 11 (Patent Applications = 1)

Average Co-Inventor Count = 11.6

ph-index = 7

Forward Citations = 119(Granted Patents)

Company Filing History:

12 out of 1,829

Schering Corporation

10 out of 2,405

Merck Sharp + Dohme Corp.

Pharmacopeia Drug Discovery, Inc.

4. 2 out of 101

Pharmacopeia Inc.

Merck Sharp + Dohme B.v.

where one patent can have more than one assignee

Years Active: 2006-2020

Loading Chart...

Loading Chart...

Loading Chart...

22 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10556957 - Anti-CD27 antibodies (2020-02-11),

2. 9969749 - Inhibitors of IRAK4 activity (2018-05-15),

3. 9943516 - Inhibitors of IRAK4 activity (2018-04-17),

4. 9932350 - Inhibitors of IRAK4 activity (2018-04-03),

5. 9926330 - Inhibitors of IRAK4 activity (2018-03-27),

6. 9206142 - Anilinopiperazine derivatives and methods of use thereof (2015-12-08),

7. 8673924 - Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors (2014-03-18),

8. 8623857 - N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1 (2014-01-07),

9. 8440443 - MEK1 polypeptides (2013-05-14),

10. 8318735 - 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors (2012-11-27),

11. 8227605 - 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors (2012-07-24),

12. 8088611 - Kinase domain polypeptide of human protein kinase B gamma (AKT3) (2012-01-03),

13. 7824491 - Method for crystallizing aurora 2 kinase catalytic domain polypeptide (2010-11-02),

14. 7807683 - N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors (2010-10-05),

15. 7776589 - Polynucleotides encoding polypeptide fragments of protein kinase B gamma (AKT3) (2010-08-17),

Title: Thierry Olivier Fischmann: Pioneering Innovator in the World of Patents and Inventions

Introduction:

Thierry Olivier Fischmann, a renowned inventor based in Scotch Plains, NJ, has made significant contributions to the world of patents and inventions through his passion for innovation and unwavering commitment to excellence. With 22 patents to his name, Fischmann's work continues to inspire the next generation of inventors worldwide.

Latest Patents:

Fischmann's latest patents include groundbreaking innovations such as Anti-CD27 antibodies, which hold promise in the treatment of diseases like cancer and infectious diseases. Additionally, his work on Inhibitors of IRAK4 activity showcases his dedication to developing novel therapeutics for IRAK4-mediated conditions.

Career Highlights:

Throughout his career, Fischmann has held pivotal roles at leading companies such as Schering Corporation and Merck Sharp & Dohme Corporation. His expertise and innovative approach have played a key role in the development of cutting-edge technologies and groundbreaking inventions in the pharmaceutical industry.

Collaborations:

Fischmann's impactful work has been further amplified through collaborations with esteemed colleagues like Vincent Stewart Madison and Timothy J Guzi. Together, they have driven forward innovative solutions that have the potential to revolutionize the field of medicine and healthcare.

Conclusion:

In conclusion, Thierry Olivier Fischmann stands as a visionary inventor whose contributions have reshaped the landscape of patents and inventions. His relentless pursuit of excellence and passion for innovation serve as a beacon of inspiration for inventors around the globe, leaving behind a lasting legacy that will continue to shape the future of technology and healthcare.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…